Andrew Gengos
2020 - Cyteir Therapeutics
In 2020, Andrew Gengos earned a total compensation of $682.7K as Chief Business Officer at Cyteir Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $111,832 |
| Option Awards | $246,205 |
| Salary | $299,674 |
| Total | $682,711 |
Gengos received $299.7K in salary, accounting for 44% of the total pay in 2020.
Gengos also received $25K in bonus, $111.8K in non-equity incentive plan and $246.2K in option awards.
Rankings
In 2020, Andrew Gengos' compensation ranked 10,053rd out of 13,090 executives tracked by ExecPay. In other words, Gengos earned more than 23.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,053 out of 13,090 | 23rd |
Division Manufacturing | 4,318 out of 5,621 | 23rd |
Major group Chemicals And Allied Products | 1,777 out of 2,254 | 21st |
Industry group Drugs | 1,555 out of 1,954 | 20th |
Industry Pharmaceutical Preparations | 1,146 out of 1,459 | 22nd |
Source: SEC filing on April 29, 2022.
Gengos' colleagues
We found two more compensation records of executives who worked with Andrew Gengos at Cyteir Therapeutics in 2020.